Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women
Overview
Authors
Affiliations
Background/aims: Renal function deteriorates with age, but a few studies have addressed this longitudinally in elderly women. Our objective was, using 5 estimated glomerular filtration rates (eGFR)-equations, to evaluate changes in renal function and association with adverse outcomes for a decade in 75-year-old women.
Methods: Plasma creatinine was measured at ages 75 (n = 1,011), 78 (n = 827), 80 (n = 689) and 85 (n = 363). Glomerular filtration rates were estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI); Modification of Diet in Renal Disease (MDRD); revised Lund-Malmö (LM-rev); Berlin Initiative Study 1 (BIS1) and Cockcroft-Gault/body surface area (CG/BSA) equations. Mortality and comorbidity were investigated in women with chronic kidney disease (CKD) stage 3A and 3B-5.
Results: Approximately, 95% of women had eGFR indicating CKD stage 2-3 and progression towards stage 3 was continuous. The women lost 22% of their eGFR during follow-up and loss accelerated between 80 and 85. Mean loss per decade was 16.6 ml/min/1.73 m(2). Women in CKD stage 3B-5 had an adjusted hazard ratio for death of 3.5 (95% CI 2.1-5.8) compared to stage 1-2 during follow-up and increased risk of diabetes, heart failure and hypertension. The CG/BSA, BIS1 and LM-rev equations continuously predicted lower eGFR than the MDRD and CKD-EPI equations.
Conclusion: eGFR in women aged 75-85 ranges from 30 to 89 ml/min/1.73 m(2) (stage 2-3). Decline was 16.6 ml/min/1.73 m(2) per decade; accelerated with age and appeared nonlinear. Women with CKD 3B-5 demonstrate an over 3-fold risk of death. eGFR <45 ml/min/1.73 m(2) was associated with mortality, confirming the new KDIGO classification 3A and 3B, as clinically applicable in the elderly.
Population Pharmacokinetics of Meropenem Across the Adult Lifespan.
Boutzoukas A, Balevic S, Hemmersbach-Miller M, Winokur P, Gu K, Chan A Clin Pharmacokinet. 2024; 64(2):229-241.
PMID: 39681779 DOI: 10.1007/s40262-024-01465-1.
Turbay-Caballero V, Ricardo A, Chen J, Missikpode C, Lash J, Aroca-Martinez G Kidney Med. 2024; 6(7):100845.
PMID: 38966681 PMC: 11222801. DOI: 10.1016/j.xkme.2024.100845.
Kidney function assessment in the geriatric population.
Muzaale A, Khan A, Glassock R, Tantisattamoa E, Ahdoot R, Al Ammary F Curr Opin Nephrol Hypertens. 2023; 33(2):267-271.
PMID: 37965904 PMC: 10872478. DOI: 10.1097/MNH.0000000000000955.
Musso C, Ricardo A, Aroca-Martinez G Int Urol Nephrol. 2023; 56(2):805-806.
PMID: 37237099 DOI: 10.1007/s11255-023-03642-w.
CHRONIC KIDNEY DISEASE IN RURAL POPULATION.
Domislovic M, Domislovic V, Stevanovic R, Fucek M, Dika Z, Karanovic S Acta Clin Croat. 2023; 61(2):228-238.
PMID: 36818921 PMC: 9934033. DOI: 10.20471/acc.2022.61.02.09.